PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study
Clinical trial NCT03837457 · TERMINATED
Trial details
- NCT number
- NCT03837457
- Sponsor
- miRagen Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2020-07-24
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.